🔗 Share this article

Texas Attorney General Paxton is suing the producers of acetaminophen, alleging the firms concealed safety concerns that the pain reliever posed to pediatric neurological development.

This legal action comes thirty days after Former President Trump advocated an unproven link between using acetaminophen - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the medication, the only pain reliever suggested for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "deceived the public by making money from pain and pushing pills without regard for the risks."

The company states there is lacking scientific proof connecting acetaminophen to autism.

"These corporations misled for generations, deliberately risking numerous people to increase profits," Paxton, a Republican, stated.

The manufacturer commented that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its official site, the company also stated it had "continuously evaluated the pertinent research and there is no credible data that indicates a established connection between using paracetamol and autism spectrum disorder."

Organizations acting on behalf of medical professionals and medical practitioners concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to treat pain and fever, which can pose significant medical dangers if ignored.

"In multiple decades of studies on the use of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in children," the organization stated.

The lawsuit references recent announcements from the Trump administration in claiming the medication is reportedly hazardous.

Recently, the former president generated worry from public health officials when he told pregnant women to "fight like hell" not to take Tylenol when sick.

The FDA then published an announcement that medical professionals should contemplate reducing the consumption of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has remains unverified.

Health Secretary RFK Jr, who manages the FDA, had promised in spring to conduct "a massive testing and research effort" that would determine the source of autism in a limited time.

But specialists cautioned that discovering a unique factor of autism - thought by researchers to be the result of a intricate combination of inherited and external influences - would be difficult.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that affects how persons encounter and interact with the surroundings, and is recognized using doctors' observations.

In his legal document, the attorney general - who supports Trump who is seeking the Senate - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "destroy any commercial messaging" that asserts Tylenol is safe for pregnant women.

The court case mirrors the grievances of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

Judicial authorities threw out the case, stating research from the parents' expert witnesses was inconclusive.